Literature DB >> 29251328

miR-141-3p suppresses proliferation and promotes apoptosis by targeting GLI2 in osteosarcoma cells.

Nan Wang1, Pengcheng Li1, Wei Liu2, Ningning Wang3, Zhi Lu4, Jianzhou Feng1, Xiandong Zeng5, Jiujie Yang1, Yong Wang1, Wei Zhao1.   

Abstract

MicroRNAs (miRNAs) have been reported as key regulators in numerous diseases including osteosarcoma. The function of microRNA-141-3p (miR-141-3p) and whether this function is achieved by regulation of GLI family zinc finger 2 (GLI2) in osteosarcoma remain unclear. In the present study, we found decreased expression of miR-141-3p, but increased expression of GLI2 in osteosarcoma tissues and cell lines. In addition, we demonstrated a negative correlation between miR-141-3p and GLI2. Furthermore, we revealed that elevation of miR-141-3p resulted in a marked inhibition of proliferation and promotion of apoptosis as well as an obviously decrease in GLI2 in osteosarcoma cell lines. Furthermore, we determined that GLI2 is a target of miR-141-3p by a constructed luciferase assay. In addition, we showed that miR-141-3p could negatively regulate GLI2 and its downstream parathyroid hormone-related protein 1 (PTHRP1). Finally, through a series of antisense experiments we confirmed that the effect of miR-141-3p on proliferation and apoptosis was achieved through the GLI2 pathway in osteosarcoma cells. The findings of the present study may provide a new target for treating osteosarcoma.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29251328     DOI: 10.3892/or.2017.6150

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  18 in total

Review 1.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

2.  miR-141-3p affects apoptosis and migration of endometrial stromal cells by targeting KLF-12.

Authors:  Yiwei Zhang; Juan Yan; Xiaowei Pan
Journal:  Pflugers Arch       Date:  2019-05-25       Impact factor: 3.657

3.  Study on effects of miR-141-3p in proliferation, migration, invasion and apoptosis of colon cancer cells by inhibiting Bcl2.

Authors:  S J Tong; X Y Zhang; H F Guo; J Yang; Y P Qi; S Lu
Journal:  Clin Transl Oncol       Date:  2021-06-04       Impact factor: 3.405

4.  Long noncoding RNA MALAT1 regulates HDAC4-mediated proliferation and apoptosis via decoying of miR-140-5p in osteosarcoma cells.

Authors:  Yuxiu Sun; Baoli Qin
Journal:  Cancer Med       Date:  2018-08-09       Impact factor: 4.452

Review 5.  Proteolytic Regulation of Parathyroid Hormone-Related Protein: Functional Implications for Skeletal Malignancy.

Authors:  Jeremy S Frieling; Conor C Lynch
Journal:  Int J Mol Sci       Date:  2019-06-08       Impact factor: 5.923

6.  Influence of MicroRNA-141 on Inhibition of the Proliferation of Bone Marrow Mesenchymal Stem Cells in Steroid-Induced Osteonecrosis via SOX11.

Authors:  Chen-Yang Meng; Fei Xue; Zhen-Qun Zhao; Ting Hao; Shi-Bing Guo; Wei Feng
Journal:  Orthop Surg       Date:  2020-01-08       Impact factor: 2.071

7.  MiR-141-3p overexpression suppresses the malignancy of osteosarcoma by targeting FUS to degrade LDHB.

Authors:  Lei Wang
Journal:  Biosci Rep       Date:  2020-06-26       Impact factor: 3.840

8.  Uncovering association networks through an eQTL analysis involving human miRNAs and lincRNAs.

Authors:  Paulo R Branco; Gilderlanio S de Araújo; Júnior Barrera; Guilherme Suarez-Kurtz; Sandro José de Souza
Journal:  Sci Rep       Date:  2018-10-09       Impact factor: 4.379

9.  Long non-coding RNA ATB promotes human non-small cell lung cancer proliferation and metastasis by suppressing miR-141-3p.

Authors:  Guojie Lu; Yaosen Zhang
Journal:  PLoS One       Date:  2020-02-24       Impact factor: 3.240

Review 10.  SHH Signaling Pathway Drives Pediatric Bone Sarcoma Progression.

Authors:  Frédéric Lézot; Isabelle Corre; Sarah Morice; Françoise Rédini; Franck Verrecchia
Journal:  Cells       Date:  2020-02-26       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.